News

The Pfizer and AstraZeneca COVID-19 shots will be combined in a ‘mix and match’ trial to see if the 2 vaccines together produce a stronger immune response

The head of the UK’s vaccine taskforce said Tuesday that a “mix and match” trial will combine both Pfizer and AstraZeneca’s COVID-19 vaccines. The trial will test whether combining the two shots works better than administering them individually. AstraZeneca and Oxford’s vaccine has not yet been approved by UK regulators, […]
The Pfizer and AstraZeneca COVID-19 shots will be combined in a ‘mix and match’ trial to see if the 2 vaccines together produce a stronger immune response
News

China’s Sinopharm has applied for regulatory approval to launch a COVID-19 vaccine for public use, but nearly 1 million people have already taken experimental shots

Chinese pharmaceutical giant Sinopharm on Tuesday applied to the country’s health regulators to launch its COVID-19 vaccines for public use, based on multiple news reports. However, close to a million people have already been injected with experimental shots since the Chinese government authorised the vaccines for emergency use in July. […]
China’s Sinopharm has applied for regulatory approval to launch a COVID-19 vaccine for public use, but nearly 1 million people have already taken experimental shots
News

AstraZeneca will likely retest its COVID-19 vaccine, CEO says after admitting an error in the first trial that may have skewed results

The UK pharmaceutical company AstraZeneca is likely to run a second global trial to assess its COVID-19 vaccine’s efficacy, its CEO told Bloomberg News on Thursday. AstraZeneca and the University of Oxford announced Monday that preliminary results indicated their two-dose vaccine could be up to 90% effective at preventing COVID-19. […]
AstraZeneca will likely retest its COVID-19 vaccine, CEO says after admitting an error in the first trial that may have skewed results
News

Vaccine trials didn’t monitor one variable: volunteers’ behaviour. ‘Masks and social distancing were left up to us,’ a participant said.

In their COVID-19 vaccine trials, Pfizer and Moderna didn’t monitor participants’ social interactions, risk-taking, or exposure after they were injected with a vaccine or placebo. Volunteers who suspected they’d gotten the vaccine may have been inclined to engage in riskier behaviour. Public-health experts say the risk of getting COVID-19 was […]
Vaccine trials didn’t monitor one variable: volunteers’ behaviour. ‘Masks and social distancing were left up to us,’ a participant said.
News

When experts say COVID-19 vaccines are 95% effective it doesn’t mean you’d have a 5% chance of getting sick

Vaccine efficacy measures how well shots prevent disease among vaccinated people in clinical studies, when compared to unvaccinated control groups. Most vaccines are not 100% effective at preventing symptomatic infections. But, if enough people get shots, they can prevent the spread of disease near-perfectly anyway. Visit Business Insider’s homepage for […]
When experts say COVID-19 vaccines are 95% effective it doesn’t mean you’d have a 5% chance of getting sick
Markets

US stocks resume climb as investors cheer COVID-19 vaccine progress

US stocks climbed on Wednesday after Pfizer and BioNTech revealed positive final-analysis data on their coronavirus vaccine. The companies’ candidate was 95% effective at protecting against COVID-19 in trial patients, Pfizer said Wednesday. The firms plan to apply for emergency-use authorization “within days.” The news lifted major indexes and spurred […]
US stocks resume climb as investors cheer COVID-19 vaccine progress
News

Fauci predicts good results from Moderna’s COVID-19 vaccine trial because it’s similar to Pfizer’s, but warns against declaring victory

Moderna announces it’s ready to submit interim data from its vaccine trial to an independent safety board. Its results are imminent. Dr. Anthony Fauci predicts positive results from Moderna’s coronavirus vaccine trial Markets respond with Moderna’s shares up 5% in premarket. Visit Business Insider’s homepage for more stories. It’s bitter-sweet. […]
Fauci predicts good results from Moderna’s COVID-19 vaccine trial because it’s similar to Pfizer’s, but warns against declaring victory
News

AstraZeneca’s COVID-19 vaccine produces an immune response in older people, raising hopes a vaccine will protect those at greatest risk

AstraZeneca’s COVID-19 vaccine triggers an immune response in elderly people as well as young adults, the drugmaker said Monday. “Immunogenicity responses were similar between older and younger adults,” an AstraZeneca spokesperson said. The vaccine, being developed with the University of Oxford, is one of the world’s leading COVID-19 vaccine candidates. […]
AstraZeneca’s COVID-19 vaccine produces an immune response in older people, raising hopes a vaccine will protect those at greatest risk
News

Remdesivir, the only antiviral authorised for COVID-19 in the US, did not improve chances of survival in a massive WHO study

A World Health Organisation study of more than 2,750 COVID-19 patients suggested that the antiviral drug remdesivir had “little or no effect” on survival. The Solidarity trial, which has not yet been peer-reviewed, found remdesivir did not “substantially affect mortality,” reduce the need to ventilate patients, or shorten hospital stays. […]
Remdesivir, the only antiviral authorised for COVID-19 in the US, did not improve chances of survival in a massive WHO study
Next Page »